Individualized alemtuzumab dosing for induction of disease remission prior to HSCT in children with HLH F. R. Achini-Gutzwiller, C. L. Vermont,J. M. van Montfrans,D. Moshous,A. M. Jansen-Hoogendijk, M. M. van Ostaijen-ten Dam,M. W. Schilham, D. J. A. Moes,A. C. Lankester,E. P. BuddinghPEDIATRIC BLOOD & CANCER(2022)引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要